CEO Letter February 07, 2022February 07, 2022
Emmaus Life Sciences is devoted to developing new novel therapeutics for patients suffering from Sickle Cell Disease. African Americans disproportionately suffer from this disease, and as we celebrate Black History Month, we are encouraged by the new attention that has been focused on our community. The coalitions we have formed through our community partners and the medical community continue to drive solutions to meet this unmet medical need.
Read More